Aichi, Japan

Yoshiaki Kubochi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Yoshiaki Kubochi and His Contributions to Pharmaceutical Science

Introduction: Yoshiaki Kubochi, an esteemed inventor based in Aichi, Japan, has made significant contributions to the field of pharmaceutical sciences. With a total of two patents, Kubochi has focused on advancing drug development processes, especially related to cephalosporin antibiotics.

Latest Patents: Yoshiaki Kubochi's latest patents include innovative methods involving acetylesterases derived from Aureobasidium pullulans IFO 4466. His first patent describes the preparation of new acetylesterases that efficiently hydrolyze cephalosporin C into deacetylcephalosporin C. Additionally, his second patent outlines a process for converting deacetylcephalosporin C back to cephalosporin C using acetylesterases produced by the same strain. These inventions are crucial for improving antibiotic synthesis and enhancing pharmaceutical efficacy.

Career Highlights: Kubochi's career is marked by his affiliation with Fujisawa Pharmaceutical Company, Ltd., where he has contributed to research and product development. His work is instrumental in fostering advancements within the pharmaceutical industry, particularly concerning antibiotic production methods.

Collaborations: Throughout his career, Yoshiaki Kubochi has collaborated with notable coworkers, including Hiroshi Imanaka and Toshio Miyoshi. Together, they have worked on projects that drive innovation in drug synthesis and contribute to the overall growth of the pharmaceutical sector.

Conclusion: Yoshiaki Kubochi stands out as a key figure in pharmaceutical innovations, holding patents that reflect his commitment to enhancing drug development processes. His work not only showcases his expertise but also has the potential to impact the future of antibiotic treatments significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…